schroders

Performance concerns for sustainable investing have risen to the fore as the Your Future Your Super (YFYS) test shortens investment horizons. The wider return outlook is more challenged too.

Recent market moves won’t be the end of ESG, but it’s as good a time as any to remind investors that there’s more to it than exclusion.

Schroders has launched likely the first dedicated fund managed directly to the Your Future, Your Super (YFYS) benchmark for alternative investments. The Global Active Allocation Fund, which has secured a foundation investment mandate from a large super fund, is a multi-asset portfolio with the objective of outperforming the YFYS benchmark applying to alternative investments and…

Manufacturers and super funds alike need to do more on the burning issue of retirement products. So far, they’ve failed to innovate. A full generation of superannuants are about to enter the decumulation phase, with little idea about what to do with the nestegg they’ve built up. And despite the new retirement income covenant, superannuation…

Member engagement is starting to rise from a very low base. But the industry is still “net nowhere” when it comes to winning their hearts and minds. It’s widely acknowledged that member engagement remains unacceptably low. Try as they might, super funds can’t seem to get members to care about their retirement savings, as evidenced…

The problem with high expectations is that you have to keep meeting them. And after a year where some funds returned 20 per cent, investors and super members are expecting more, more, more. Investors are relentlessly cheerful creatures. According to Schroders’ latest Global Investor Study, Australian investors (defined here as those expecting to invest the…

The value vs growth competition isn’t a competition, according to Schroders. Value will always outperform because it exploits “the one thing that never really changes”: human beings. Markets have seen a period of very strong value performance since the announcement and rollout of effective Covid-19 vaccines – the so-called “Vaccine Monday” – as markets reappraised…

Short and long-term factors are benefitting investors and their managers which have either entered the private markets space or expanded their capabilities. To the chagrin of detractors, Australia’s big not-for-profit funds can hang their hats largely on private markets for much of their outperformance. We all know UK based global manager Schroders is very old,…

The case for venture capital as an institutional investment has never been more apparent. As others in the private markets generally are saying, “where else are you going to invest?” While a new model doesn’t make it any easier for Australia’s big funds to invest locally, it does so globally. The new model consists of…